Latest Decheng Capital LLC Stock Portfolio
Decheng Capital LLC Performance:
2024 Q3: -2.04%YTD: 32.48%
Performance for 2024 Q3 is -2.04%, and YTD is 32.48%.
About Decheng Capital LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Decheng Capital LLC reported an equity portfolio of $422.2 Millions as of 30 Sep, 2024.
The top stock holdings of Decheng Capital LLC are , NUVB, PHAT. The fund has invested 49% of it's portfolio in CG ONCOLOGY INC and 14.1% of portfolio in NUVATION BIO INC.
They significantly reduced their stock positions in GRAIL INC and ILLUMNIA, INC. (ILMN). Decheng Capital LLC opened new stock positions in LONGBOARD PHARMACEUTICALS IN (LBPH) and REVOLUTION MEDICINES INC(NSM) (RVMD). The fund showed a lot of confidence in some stocks as they added substantially to ARCELLX INC (ACLX), NUVATION BIO INC. (NUVB) and NEWAMSTERDAM PHARMA CO NV (NAMS).
The top stock holdings of Decheng Capital LLC are , NUVB, PHAT. The fund has invested 49% of it's portfolio in CG ONCOLOGY INC and 14.1% of portfolio in NUVATION BIO INC.
They significantly reduced their stock positions in GRAIL INC and ILLUMNIA, INC. (ILMN). Decheng Capital LLC opened new stock positions in LONGBOARD PHARMACEUTICALS IN (LBPH) and REVOLUTION MEDICINES INC(NSM) (RVMD). The fund showed a lot of confidence in some stocks as they added substantially to ARCELLX INC (ACLX), NUVATION BIO INC. (NUVB) and NEWAMSTERDAM PHARMA CO NV (NAMS).
Decheng Capital LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Decheng Capital LLC made a return of -2.04% in the last quarter. In trailing 12 months, it's portfolio return was 58.3%.
New Buys
| Ticker | $ Bought |
|---|---|
| longboard pharmaceuticals in | 1,878,150 |
| revolution medicines inc(nsm) | 90,700 |
New stocks bought by Decheng Capital LLC
Additions
| Ticker | % Inc. |
|---|---|
| arcellx inc | 1,699 |
| nuvation bio inc. | 273 |
| newamsterdam pharma co nv | 47.5 |
| phathom pharmaceuticals inc | 47.06 |
| 4d molecular therapeutics in | 14.37 |
| legend biotech corp-adr | 10.15 |
| krystal biotech inc | 9.12 |
| merus nv | 5.58 |
Additions to existing portfolio by Decheng Capital LLC
Reductions
| Ticker | % Reduced |
|---|---|
| grail inc | -46.58 |
| illumnia, inc. | -12.87 |
Decheng Capital LLC reduced stake in above stock
Sold off
Sector Distribution
Decheng Capital LLC has about 54.9% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 54.9 |
| Healthcare | 44 |
Market Cap. Distribution
Decheng Capital LLC has about 2.9% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 57.2 |
| SMALL-CAP | 26.4 |
| MID-CAP | 9.6 |
| MICRO-CAP | 3 |
| LARGE-CAP | 2.9 |
Stocks belong to which Index?
About 38.3% of the stocks held by Decheng Capital LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 61.7 |
| RUSSELL 2000 | 35.4 |
| S&P 500 | 2.9 |
Decheng Capital LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Decheng Capital LLC
Decheng Capital LLC has 26 stocks in it's portfolio. About 87.5% of the portfolio is in top 10 stocks. NUVB proved to be the most loss making stock for the portfolio. PHAT was the most profitable stock for Decheng Capital LLC last quarter.
Last Reported on: 15 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACLX | arcellx inc | 0.42 | 21,177 | 1,768,490 | added | 1,699 | ||
| ATRC | atricure inc. | 0.18 | 26,797 | 751,388 | unchanged | 0.00 | ||
| AURA | aura biosciences, inc. | 1.09 | 515,555 | 4,593,600 | unchanged | 0.00 | ||
| BYSI | beyondspring inc. | 2.69 | 4,958,140 | 11,354,100 | unchanged | 0.00 | ||
| CRNX | crinetics pharmaceuticals in | 1.91 | 157,958 | 8,071,650 | unchanged | 0.00 | ||
| CYTK | cytokinetics inc | 1.18 | 94,043 | 4,965,470 | unchanged | 0.00 | ||
| EQ | equillium inc. | 0.88 | 4,447,310 | 3,700,160 | unchanged | 0.00 | ||
| FDMT | 4d molecular therapeutics in | 1.02 | 397,835 | 4,300,600 | added | 14.37 | ||
| ILMN | illumnia, inc. | 2.93 | 94,767 | 12,358,600 | reduced | -12.87 | ||
| KRYS | krystal biotech inc | 3.09 | 71,772 | 13,064,700 | added | 9.12 | ||
| LBPH | longboard pharmaceuticals in | 0.44 | 56,350 | 1,878,150 | new | |||
| MRUS | merus nv | 2.24 | 189,098 | 9,447,340 | added | 5.58 | ||
| NAMS | newamsterdam pharma co nv | 2.32 | 590,000 | 9,794,000 | added | 47.5 | ||
| NUVB | nuvation bio inc. | 14.08 | 25,954,400 | 59,435,700 | added | 273 | ||
| NUVB | nuvation bio inc. | 0.01 | 646,057 | 63,249 | unchanged | 0.00 | ||
| PHAT | phathom pharmaceuticals inc | 5.35 | 1,250,000 | 22,600,000 | added | 47.06 | ||
| PYXS | pyxis oncology, inc (formerly apexigen) | 0.28 | 326,810 | 1,199,390 | unchanged | 0.00 | ||
| RCUS | arcus biosciences, inc | 3.15 | 869,790 | 13,299,100 | unchanged | 0.00 | ||
| RVMD | revolution medicines inc(nsm) | 0.02 | 2,000 | 90,700 | new | |||
| SMFR | genedx holdings corp. | 1.04 | 103,604 | 4,396,950 | unchanged | 0.00 | ||